Integrating and Disseminating Pre-Exposure Prophylaxis (PrEP) Screening and Dispensing for Black Men Who Have Sex With Men in Atlanta, Georgia: Protocol for Community Pharmacies.
Integrating and Disseminating Pre-Exposure Prophylaxis (PrEP) Screening and Dispensing for Black Men Who Have Sex With Men in Atlanta, Georgia: Protocol for Community Pharmacies.
复制标题
DOI：
10.2196/35590
复制
发表时间：
2022-02-09
影响因子：
1.7
通讯作者：
Young HN
中科院分区：
文献类型：
--
作者：
Crawford ND;Harrington KRV;Alohan DI;Sullivan PS;Holland DP;Klepser DG;Quamina A;Siegler AJ;Young HN
在美国，与男性发生性关系的黑人男性（BMSM）感染艾滋病毒的比率高得惊人。暴露前预防（PrEP）可以将男男性行为者感染艾滋病毒的风险降低99%，但在PrEP的摄取方面存在深刻的种族差异。BMSM的PrEP摄取率低是由于PrEP获取困难，包括PrEP处方医生的位置不方便，对医生的不信任和耻辱，这限制了关于PrEP及其副作用的沟通。以前的工作表明，在低收入，服务不足的社区的药店提供艾滋病毒预防服务是可行的，可以减少耻辱，因为药店提供了一系列不那么耻辱的卫生服务（如疫苗接种）。我们提出了一个协议的药房PrEP模型，旨在解决的挑战和障碍，以药房为基础的PrEP专门为BMSM。我们的目标是为BMSM开发一种可持续的药房PrEP交付模式，可以实施以增加低收入，服务不足的社区的PrEP获取。本研究设计是一项试点干预措施，以测试药房工作人员和BMSM之间的药房PrEP交付模式。我们将研究PrEP交付模式的可行性，可接受性和安全性，并收集其影响和成本的早期证据。将采用混合方法，包括三个研究阶段：（1）完成形成阶段，对主要利益相关者进行定性访谈;（2）完成过渡试点阶段，以评估客户在COVID-19期间在药店接受PrEP的资格和意愿;以及（3）计划的试点干预阶段，将在亚特兰大低收入，服务不足的社区的2家药店测试交付模式。形成阶段的数据显示，BMSM、药剂师和药房工作人员强烈支持基于药房的PrEP提供。确定了促进在药房实施PrEP筛查和传播的重要因素。在过渡试点阶段，我们确定了81名有资格参加试点阶段的个人。药店已被证明是一个可行的来源，为白色男子谁与男性发生性关系，但未能达到最危险的，脆弱的人群（即BMSM）提供PrEP。增加PrEP的获得和吸收将减少艾滋病毒的发病率和艾滋病毒的种族不平等。需要进行转化研究，以建立进一步的证据，并扩大基于药房的PrEP服务，特别是针对与艾滋病毒预防资源脱节的人群。DERR1-10.2196/35590
Black men who have sex with men (BMSM) suffer from alarmingly high rates of HIV in the United States. Pre-exposure prophylaxis (PrEP) can reduce the risk of HIV infection by 99% among men who have sex with men, yet profound racial disparities in the uptake of PrEP persist. Low PrEP uptake in BMSM is driven by poor access to PrEP, including inconvenient locations of PrEP-prescribing physicians, distrust of physicians, and stigma, which limit communication about PrEP and its side effects. Previous work indicates that offering HIV prevention services in pharmacies located in low-income, underserved neighborhoods is feasible and can reduce stigma because pharmacies offer a host of less stigmatized health services (eg, vaccinations). We present a protocol for a pharmacy PrEP model that seeks to address challenges and barriers to pharmacy-based PrEP specifically for BMSM. We aim to develop a sustainable pharmacy PrEP delivery model for BMSM that can be implemented to increase PrEP access in low-income, underserved neighborhoods. This study design is a pilot intervention to test a pharmacy PrEP delivery model among pharmacy staff and BMSM. We will examine the PrEP delivery model’s feasibility, acceptability, and safety and gather early evidence of its impact and cost with respect to PrEP uptake. A mixed-methods approach will be performed, including three study phases: (1) a completed formative phase with qualitative interviews from key stakeholders; (2) a completed transitional pilot phase to assess customer eligibility and willingness to receive PrEP in pharmacies during COVID-19; and (3) a planned pilot intervention phase which will test the delivery model in 2 Atlanta pharmacies in low-income, underserved neighborhoods. Data from the formative phase showed strong support of pharmacy-based PrEP delivery among BMSM, pharmacists, and pharmacy staff. Important factors were identified to facilitate the implementation of PrEP screening and dissemination in pharmacies. During the transitional pilot phase, we identified 81 individuals who would have been eligible for the pilot phase. Pharmacies have proven to be a feasible source for offering PrEP for White men who have sex with men but have failed to reach the most at-risk, vulnerable population (ie, BMSM). Increasing PrEP access and uptake will reduce HIV incidence and racial inequities in HIV. Translational studies are required to build further evidence and scale pharmacy-based PrEP services specifically for populations that are disconnected from HIV prevention resources. DERR1-10.2196/35590
登录
查看更多内容
影响因子：
8.5
作者：
Hall HI;Song R;Tang T;An Q;Prejean J;Dietz P;Hernandez AL;Green T;Harris N;McCray E;Mermin J
通讯作者：
Mermin J
影响因子：
4.2
作者：
Lewis, Crystal Fuller;Rivera, Alexis V.;Amesty, Silvia
通讯作者：
Amesty, Silvia
影响因子：
3.2
作者：
Carayon, Pascale;Wooldridge, Abigail;Kelly, Michelle M.
通讯作者：
Kelly, Michelle M.
影响因子：
5.7
作者：
Guerry, SL;Bauer, HM;Bolan, G
通讯作者：
Bolan, G
影响因子：
2.1
作者：
Lecher, Shirley Lee;Shrestha, Ram K.;Weidle, Paul J.
通讯作者：
Weidle, Paul J.